Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical stage biotechnology company with a mission to advance dermatology, wound care, and infection control, visits the Nasdaq MarketSite in Times Square to celebrate its listing on Nasdaq Global Markets. In honor of the occasion, Bradley E. Burnam, Founder and CEO rings the Closing Bell.